期刊
MOLECULAR PHARMACEUTICS
卷 17, 期 4, 页码 1139-1147出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.molpharmaceut.9b01181
关键词
immunopositron emission tomography; TRA-1-60; tumor initiating cells; metastasis
资金
- National Institutes of Health [NIH T32-CA009531]
- NIH Cancer Center [P30 CA022453]
- Perinatology Research Branch of the National Institutes of Child Health and Development at Wayne State University
TRA-1-60 (TRA) is a cell-surface antigen implicated in drug resistance, relapse, and recurrence. Its expression has been reported in breast, prostate, pancreatic, ovarian tumors, and follicular lymphoma, which paved the development of the therapeutic antibody, Bstrongomab (Bsg), and its drug conjugates. Because patient selection is critical to achieve clinical benefit, a noninvasive imaging agent to select TRA+ lesions in patients is needed. Herein, we report the development of the immunopositron emission tomography (immunoPET) radiotracer Zr-89-radiolabeled Bsg and its potential to delineate TRA+ tumors. Bsg was conjugated to the bifunctional chelator desferrioxamine (DFO) and radiolabeled with [Zr-89]Zr-oxalate. [Zr-89]Zr-DFO-Bsg was characterized in vitro and evaluated in vivo for uptake and specificity in high and low TRA-expressing BxPC-3 pancreatic and PC-3 prostate cancer models, respectively. Uptake was compared against [Zr-89]Zr-DFO-IgG, a nonspecific control radiotracer. Immunohistochemical (IHC) staining of patient cancer tissues using Bsg was performed to explore its clinical significance. A specific activity of 0.18 +/- 0.01 GBq/mg (4.8 +/- 0.3 mCi/mg) was obtained for [Zr-89]Zr-DFO-Bsg. BxPC-3 xenografts exhibited three-fold higher radiotracer uptake compared to [Zr-89]Zr-DFO-IgG. Competitive saturation studies using BxPC-3 xenografts further confirmed tracer specificity. The TRA-specific probe had lower accumulation in PC-3 xenografts. Ex vivo autoradiographs correlated with TRA expression from the histopathology of the resected tumor xenografts. Additionally, patient cancer tissues demonstrated positive staining with Bsg with metastatic lesions exhibiting the highest staining. This study demonstrates the potential of [Zr-89-DFO-Bsg as an imaging agent for noninvasive detection of TRA+ tumors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据